Increased arginase levels in heart failure represent a therapeutic target to rescue microvascular perfusion

Clinical Hemorheology and Microcirculation

Volumn 54, Issue 1, 2013, Pages 75-85

  Quitter, Felix ^a   Figulla, Hans R ^a   Ferrari, Markus ^a   Pernow, John ^b   Jung, Christian ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

arginase; heart failure; intravital microscopy; Microcirculation; SDF

Indexed keywords

ARGINASE 1; N(G) METHYLARGININE;

ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MICROCIRCULATION; MICROSCOPY; NEW YORK HEART ASSOCIATION CLASS;

AGED; ARGINASE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED;

EID: 84878874664     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2012-1617     Document Type: Article

References (36)

1. Ethical Guidelines for Publication in Clinical Hemorheology and Microcirculation, Clin Hemorheol Microcirc 44 (2010), 1-2.
2. J. Bauersachs and J. D. Widder, Endothelial dysfunction in heart failure, Pharmacol Rep 60 (2008), 119-126.
3. D. E. Berkowitz, R. White, D. Li, K. M. Minhas, A. Cernetich, S. Kim, S. Burke, A. A. Shoukas, D. Nyhan, H. C. Champion and J. M. Hare, Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels, Circulation 108 (2003), 2000-2006.
4. H. Cai and D. G. Harrison, Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress, Circ Res 87 (2000), 840-844.
5. K. Damman, A. A. Voors, G. Navis, D. J. van Veldhuisen and H. L. Hillege, The cardiorenal syndrome in heart failure, Prog Cardiovasc Dis 54 (2011), 144-153.
6. A. P. Davel, C. F. Wenceslau, E. H. Akamine, F. E. Xavier, G. K. Couto, H. T. Oliveira and L. V. Rossoni, Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: An update, Braz J Med Biol Res 44 (2011), 920-932.
7. D. De Backer, J. Creteur, M. -J. Dubois, Y. Sakr and J. -L. Vincent, Microvascular alterations in patients with acute severe heart failure and cardiogenic shock, American Heart Journal 147 (2004), 91-99.
8. D. De Backer, J. A. Ortiz and D. Salgado, Coupling microcirculation to systemic hemodynamics, Curr Opin Crit Care 16 (2010), 250-254.
9. C. A. den Uil, K. Caliskan, W. K. Lagrand, M. van der Ent, L. S. Jewbali, J. P. van Kuijk, P. E. Spronk and M. L. Simoons, Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure, Intensive Care Med 35 (2009), 1893-1899.
10. C. A. den Uil, W. K. Lagrand, P. E. Spronk, M. van der Ent, L. S. Jewbali, J. J. Brugts, C. Ince and M. L. Simoons, Lowdose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure, Eur J Heart Fail 11 (2009), 386-390.
11. C. A. den Uil,W. K. Lagrand, M. van der Ent, L. S. Jewbali, J. M. Cheng, P. E. Spronk and M. L. Simoons, Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock, Eur Heart J 31 (2010), 3032-3039.
12. G. F. DiBona, Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function, Hypertension 36 (2000), 1083-1088.
13. K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, A. W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S. G. Priori and K. Swedberg, ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM), Eur J Heart Fail 10 (2008), 933-989.
14. P. Dube and K. T. Weber, Congestive heart failure: Pathophysiologic consequences of neurohormonal activation and the potential for recovery: Part I, Am J Med Sci 342 (2011), 348-351.
15. W. Durante, F. K. Johnson and R. A. Johnson, Arginase: A critical regulator of nitric oxide synthesis and vascular function, Clin Exp Pharmacol Physiol 34 (2007), 906-911.
16. T. Eleftheriadis, V. Liakopoulos, G. Antoniadi, I. Stefanidis and G. Galaktidou, Arginase type I as a marker of coronary heart disease in hemodialysis patients, Int Urol Nephrol 43 (2011), 1187-1194.
17. A. T. Gonon, C. Jung, A Katz, H. Westerblad, A. Shemyakin, P. -O. Sjöquist, J. O. Lundberg, J. Pernow, Local Arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production, PLoS One 7 (2012), e42038.
18. J. Gronros, C. Jung, J. O. Lundberg, R. Cerrato, C. G. Ostenson and J. Pernow, Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats, Am J Physiol Heart Circ Physiol 300 (2011), H1174-H1181.
19. C. Jung, M. Ferrari, R. Gradinger,M. Fritzenwanger, R. Pfeifer,M. Schlosser, T. C. Poerner, B. R. Brehm and H. R. Figulla, Evaluation of the microcirculation during extracorporeal membrane-oxygenation, Clin Hemorheol Microcirc 40 (2008), 311-314.
20. C. Jung, M. Ferrari, C. Rodiger, M. Fritzenwanger, B. Goebel, A. Lauten, R. Pfeifer and H. R. Figulla, Evaluation of the sublingual microcirculation in cardiogenic shock, Clin Hemorheol Microcirc 42 (2009), 141-148.
21. C. Jung, A. T. Gonon, P. O. Sjoquist, J. O. Lundberg and J. Pernow, Arginase inhibition mediates cardioprotection during ischaemia-reperfusion, Cardiovasc Res 85 (2010), 147-154.
22. C. Jung, C. Rodiger,M. Fritzenwanger, J. Schumm, A. Lauten, H. R. Figulla and M. Ferrari, Acute microflow changes after stop and restart of intra-aortic balloon pump in cardiogenic shock, Clin Res Cardiol 98 (2009), 469-475.
23. J. H. Kim, L. J. Bugaj, Y. J. Oh, T. J. Bivalacqua, S. Ryoo, K. G. Soucy, L. Santhanam, A. Webb, A. Camara, G. Sikka, D. Nyhan, A. A. Shoukas, M. Ilies, D. W. Christianson, H. C. Champion and D. E. Berkowitz, Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats, J Appl Physiol 107 (2009), 1249-1257.
24. V. Kon, A. Yared and I. Ichikawa, Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive heart failure and acute extracellular fluid volume depletion, J Clin Invest 76 (1985), 1913-1920.
25. U. Landmesser, S. Spiekermann, S. Dikalov, H. Tatge, R. Wilke, C. Kohler, D. G. Harrison, B. Hornig and H. Drexler, Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: Role of xanthine-oxidase and extracellular superoxide dismutase, Circulation 106 (2002), 3073-3078.
26. A. Lauten, M. Ferrari, B. Goebel,W. Rademacher, J. Schumm, O. Uth, M. Kiehntopf, H. R. Figulla and C. Jung, Microvascular tissue perfusion is impaired in acutely decompensated heart failure and improves following standard treatment, Eur J Heart Fail 13 (2011), 711-717.
27. H. Li, C. J. Meininger, J. R. Hawker Jr, T. E. Haynes, D. Kepka-Lenhart, S. K. Mistry, S. M. Morris Jr and G. Wu, Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells, Am J Physiol Endocrinol Metab 280 (2001), E75-E82.
28. X. F. Ming, C. Barandier, H. Viswambharan, B. R. Kwak, F. Mach, L. Mazzolai, D. Hayoz, J. Ruffieux, S. Rusconi, J. P. Montani and Z. Yang, Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: Implications for atherosclerotic endothelial dysfunction, Circulation 110 (2004), 3708-3714.
29. O. Parodi, R. De Maria and E. Roubina, Redox state, oxidative stress and endothelial dysfunction in heart failure: The puzzle of nitrate-thiol interaction, J Cardiovasc Med (Hagerstown) 8 (2007), 765-774.
30. M. V. Pokrovskiy, M. V. Korokin, S. A. Tsepeleva, T. G. Pokrovskaya, V. V. Gureev, E. A. Konovalova, O. S. Gudyrev, V. I. Kochkarov, L. V. Korokina, E. N. Dudina, A. V. Babko, E. G. Terehova, Arginase inhibitor in the pharmacological correction of endothelial dysfunction, Int J Hypertens 2011 (2011), 515047.
31. D. R. Salgado, R. Favory, J. R. Rocco, E. Silva, J. A. Ortiz, K. Donadello, J. Creteur, J. L. Vincent and D. De Backer, Microcirculatory effects of angiotensin II inhibitors in patients with severe heart failure, Clin Hemorheol Microcirc (2012), DOI: 10. 3233/CH-2012-1569
32. E. Shantsila, B. J. Wrigley, A. D. Blann, P. S. Gill and G. Y. Lip, A contemporary view on endothelial function in heart failure, Eur J Heart Fail 14 (2012), 873-881.
33. P. Stralin, K. Karlsson, B. O. Johansson and S. L. Marklund, The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase, Arterioscler Thromb Vasc Biol 15 (1995), 2032-2036.
34. S. A. Timmer, T. Germans,W. P. Brouwer,M. Lubberink, J. van der Velden, A. A. Wilde, I. Christiaans, A. A. Lammertsma, P. Knaapen and A. C. van Rossum, Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction, Eur J Heart Fail 13 (2011), 1283-1289.
35. M. Visser, W. J. Paulus, M. A. Vermeulen, M. C. Richir, M. Davids, W. Wisselink, B. A. de Mol and P. A. van Leeuwen, The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature, Eur J Heart Fail 12 (2010), 1274-1281.
36. A. R. White, S. Ryoo, D. Li, H. C. Champion, J. Steppan, D. Wang, D. Nyhan, A. A. Shoukas, J. M. Hare and D. E. Berkowitz, Knockdown of arginase I restores NO signaling in the vasculature of old rats, Hypertension 47 (2006), 245-251.